| 4 | AMERICAN CENTURY COMPANIES INC | 2.5M | $92.5M | +20.6% | 4.387% | 0.04% |
| 5 | DIMENSIONAL FUND ADVISORS LP | 2.4M | $87.1M | +15.3% | 4.135% | 0.02% |
| 6 | VANGUARD CAPITAL MANAGEMENT LLC | 2.1M | $76.6M | +0.1% | 3.636% | 0.00% |
| 7 | STATE STREET CORP | 1.9M | $67.7M | +4.2% | 3.212% | 0.00% |
| 8 | ARMISTICE CAPITAL, LLC | 1.6M | $56.9M | -3.7% | 2.702% | 0.70% |
| 9 | GEODE CAPITAL MANAGEMENT, LLC | 1.4M | $52.5M | +9.1% | 2.492% | 0.00% |
| 10 | ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 1.3M | $47.8M | -5.0% | 2.267% | 0.02% |
| 11 | RENAISSANCE TECHNOLOGIES LLC | 1.2M | $43.5M | +10.9% | 2.065% | 0.06% |
| 12 | TWO SIGMA INVESTMENTS, LP | 959K | $34.9M | +30.8% | 1.657% | 0.03% |
| 13 | AQR CAPITAL MANAGEMENT LLC | 934K | $34.0M | +30.4% | 1.614% | 0.01% |
| 14 | Valor Management LLC | 818K | $29.8M | +598.4% | 1.413% | 0.03% |
| 15 | MORGAN STANLEY | 734K | $26.7M | -28.8% | 1.267% | 0.00% |
| 16 | UBS Group AG | 603K | $22.0M | +34.6% | 1.042% | 0.00% |
| 17 | DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt | 551K | $20.1M | -2.8% | 0.952% | 0.02% |
| 18 | Invesco Ltd. | 529K | $19.2M | -15.9% | 0.913% | 0.00% |
| 19 | JPMORGAN CHASE & CO | 514K | $18.2M | -37.6% | 0.888% | 0.00% |
| 20 | venBio Partners LLC | 472K | $17.2M | -3.5% | 0.816% | 3.31% |
| 21 | NORTHERN TRUST CORP | 471K | $17.2M | +11.3% | 0.814% | 0.00% |
| 22 | BNP PARIBAS FINANCIAL MARKETS | 438K | $16.0M | -19.6% | 0.757% | 0.01% |
| 23 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 424K | $15.4M | +3.0% | 0.732% | 0.00% |
| 24 | NOMURA HOLDINGS INC | 418K | $15.2M | -19.8% | 0.722% | 0.02% |
| 25 | GOLDMAN SACHS GROUP INC | 404K | $14.7M | -67.4% | 0.697% | 0.00% |
denotes a marquee investor (Buffett, Burry, ARK, Tiger Global, Pershing Square, Baupost and other widely-followed managers). “% of Fund” shows how much of that investor’s total 13F portfolio is invested in HRMY — a direct measure of their conviction.
| 86.34% |
| 3.95 pp |
| $1.54B |
| 10.0% |
| Q4 2024 | 246 | +7.9% | 90.29% | +3.15 pp | $1.71B | 11% |
| Q3 2024 | 228 | — | 87.14% | — | $1.93B | — |
Source: SEC 13F institutional filings. Ownership % requires market cap data and will show once linked. Δ columns compare to the immediately prior filed quarter.
47 institutions opened new positions in HRMY during Q2 2026, while 33 fully exited. 218 added to existing positions and 50 trimmed.
HRMY institutional ownership fell by 4.07 percentage points quarter-over-quarter, with a net change of +17 holders.
The top 10 institutions account for 53.5% of all reported 13F value in HRMY, and the top 25 account for 72.4%.
All data is sourced from SEC Form 13F filings, which institutional investment managers with at least $100M in assets are required to file each quarter. We process every 13F filing from EDGAR and recompute the aggregates after each cycle. Insider transactions are sourced from Form 4 filings.
Harmony Biosciences Holdings, Inc. (HRMY) Institutional Ownership